EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Complete dissection of right paratracheal lymph nodes (stations 2R and 4R ) is critical to improve the prognosis of lung cancer patients: A retrospective cohort study

Kejia Zhao, Jiandong Mei iD, Binbin Hu, Chenglin Guo, Shiyou Wei, Xudong Yang, Zhenyu Yang, Jian Zhang, Yin Ku, Yao Zheng, Di Wu, Shasha Li und 3 weitere

Thoracic Cancer · 2023

DOI: 10.1111/1759-7714.15122 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Thoracic Cancer, 2023. Verfasst von Kejia Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, The 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The optimal extent of mediastinal lymph node dissection is still under debate. This study aimed to investigate the prognostic impact of complete dissection of right paratracheal lymph nodes (LNs) in right‐sided non‐small cell lung cancer (NSCLC) and evaluate the potential patient population who will particularly benefit from right paratracheal node dissection (RPND).

Methods

Between January 2009 and December 2019, we retrospectively reviewed 2650 patients with primary right‐sided NSCLC who underwent pulmonary surgery with lymphadenectomy in the Western China Lung Cancer Database. A total of 2447 patients received both 2R and 4R LNs dissection (complete RPND group), 162 patients received only 2R or 4R LNs dissection (incomplete RPND group), and 41 patients received neither 2R nor 4R LNs dissection (no RPND group). Overall survival (OS) was analyzed.

Results

The metastasis rates in stations 2R and 4R were 6.5% and 8.0%, respectively. In stage N2 patients, the frequency of involvement of stations 2R/4R was 74.8%. The complete RPND group had a significantly better survival than the incomplete and no RPND group (5‐year OS, 79.5% vs. 72.7% vs. 65.5%; p < 0.001). In the multivariate analysis, status of RPND (incomplete RPND vs. complete RPND: HR 1.45, 95% CI: 1.10–1.90; p = 0.009; no RPND vs. complete RPND: HR 2.25, 95% CI: 1.37 to 3.69; p = 0.001), age, gender, tumor size, histological type, pTNM stage, pT stage, pN stage, and adjuvant treatment were independent factors for OS.

Conclusions

Complete RPND brings survival benefits to patients with right‐sided NSCLC. We suggest complete RPND as a standard procedure for patients with right‐sided NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungHumansRetrospective StudiesPneumonectomyLymphatic MetastasisLymph NodesPrognosisLymph Node ExcisionNeoplasm Staging

Stichwörter der Autor:innen

2R lymph node4R lymph nodenon-small cell lung cancerprognosisright paratracheal node dissection

Autor:innen und Institutionen

  • Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China.
  • Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Chengdu, China.
  • Department of Radiation Oncology, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Thoracic Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China.

ORCID-Profile: Jiandong Mei, Lunxu Liu

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • The 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University

Zitieren

APA

Zhao, K., Mei, J., Hu, B., Guo, C., Wei, S., Yang, X., Yang, Z., Zhang, J., Ku, Y., Zheng, Y., Wu, D., Li, S., Mao, Y., Ding, Y., & Liu, L. (2023). Complete dissection of right paratracheal lymph nodes (stations 2R and 4R ) is critical to improve the prognosis of lung cancer patients: A retrospective cohort study. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15122

Vancouver

Zhao K, Mei J, Hu B, Guo C, Wei S, Yang X, et al. Complete dissection of right paratracheal lymph nodes (stations 2R and 4R ) is critical to improve the prognosis of lung cancer patients: A retrospective cohort study. Thoracic Cancer. 2023. doi:10.1111/1759-7714.15122

BibTeX
@article{Zhao2023,
  author = {Zhao, Kejia and Mei, Jiandong and Hu, Binbin and Guo, Chenglin and Wei, Shiyou and Yang, Xudong and Yang, Zhenyu and Zhang, Jian and Ku, Yin and Zheng, Yao and Wu, Di and Li, Shasha and Mao, Yonghong and Ding, Yu and Liu, Lunxu},
  title = {Complete dissection of right paratracheal lymph nodes (stations 2R and 4R ) is critical to improve the prognosis of lung cancer patients: A retrospective cohort study},
  journal = {Thoracic Cancer},
  year = {2023},
  doi = {10.1111/1759-7714.15122}
}
Kostenlos starten →